Airship AI Announces $2.35 Million Sole-Source Contract Award within the Department of Justice for Outpost AI Edge Appliances
April 25, 2024 08:31 ET
|
Airship AI
Airship AI Announces $2.35 Million Sole-Source Contract Award within the Department of Justice for Outpost AI Edge Appliances
Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
April 25, 2024 08:30 ET
|
Journey Medical Corporation
SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily...
Star Equity Holdings Announces its KBS Builders Business Unit Closed a $4 Million Revolving Line of Credit with KeyBank
April 25, 2024 08:30 ET
|
Star Equity Holdings, Inc.
OLD GREENWICH, Conn., April 25, 2024 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star” or the “Company”), a diversified holding company, announced today that its KBS...
Hanmi Financial Declares Cash Dividend of $0.25 per share and Announces New Share Repurchase Authorization
April 25, 2024 08:30 ET
|
Hanmi Bank
LOS ANGELES, April 25, 2024 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced that its Board of Directors...
Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip
April 25, 2024 08:30 ET
|
Autonomix Medical, Inc.
THE WOODLANDS, TX, April 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to...
Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene
April 25, 2024 08:30 ET
|
Apollomics Inc.
Apollomics’ partner in China, Avistone, received approval from National Medical Products Administration of China to expand the use of vebreltinib to the treatment of gliomas with PTPRZ1-MET fusion...
Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
April 25, 2024 08:30 ET
|
Elicio Therapeutics, Inc.
BOSTON, April 25, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel...
Leading Office Furniture Manufacturer Implements Bridgeline’s HawkSearch
April 25, 2024 08:30 ET
|
Bridgeline Digital, Inc.
WOBURN, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of marketing technology software, announced today that a leading office-supply manufacturer has...
SoundThinking Sets First Quarter 2024 Conference Call for Tuesday, May 14, 2024 at 4:30 p.m. ET
April 25, 2024 08:30 ET
|
SoundThinking, Inc.
FREMONT, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- SoundThinking, Inc. (Nasdaq: SSTI) (formerly ShotSpotter, Inc.), a leading public safety technology company, will hold a conference call on...
New Season of Gaia Original Series The Journey of Remembering with Matías De Stefano Returned Monday, April 22
April 25, 2024 08:30 ET
|
Gaia, Inc.
BOULDER, Colo., April 25, 2024 (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ: GAIA), a conscious media and community company, announced that the second season of its highly-anticipated original series...